Journals
Publish with us
Publishing partnerships
About us
Blog
BioMed Research International
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
BioMed Research International
/
2014
/
Article
/
Tab 2
/
Research Article
Isocitrate Dehydrogenase-1 Mutations as Prognostic Biomarker in Glioblastoma Multiforme Patients in West Bohemia
Table 2
The representation of IDH1 R132H mutation in primary versus secondary glioblastomas.
Glioblastoma type
Primary GBM (
)
Secondary GBM (
)
Mutation status [
]
IDH1 R132H
4 (15.3%)
16 (89.9%)
IDH1 wild-type
22 (84.7%)
2 (11.1%)